MEPs propose blueprint for safer health care, inc antibiotic resistance

19 May 2015
eu-european-union-flag

Suggested ways to improve patient safety, including tackling growing resistance to human and veterinary antibiotics, using today’s treatments more responsibly and promoting innovation, are set out in a resolution voted on Tuesday in the European Parliament.

Members of the European Parliament (MEP) note that 8%-12% of patients in European Union hospitals suffer adverse events, such as health care-related infections, which are implicated in 37,000 deaths a year and place a heavy burden on limited health service budgets.

“Austerity measures cannot be imposed in such a way that they affect the safety of patients, staff or experts in hospitals,” said lead MEP Piernicola Pedicini (EFDD, Italy), whose recommendations were approved by 637 votes to 32, with 10 abstentions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical